Search
Sulfapyridine
go.drugbank.com/drugs/DB00891ApprovedWithdrawnAntibacterial, potentially toxic, and previously used to treat certain skin diseases. No longer prescribed.
Categories: Genito Urinary System and Sex HormonesProteasome subunit alpha type-3
go.drugbank.com/bio_entities/BE0003912TargetHumansComponent of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. … This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex).
Synonyms: Multicatalytic endopeptidase complex subunit C8Linaprazan
go.drugbank.com/drugs/DB20602InvestigationalThe usage of the INN stem '-prazan' in the name indicates that Linaprazan is a proton pump inhibitor, not dependent on acid activation.
Prusogliptin
go.drugbank.com/drugs/DB20606InvestigationalThe usage of the INN stem '-gliptin' in the name indicates that Prusogliptin is a dipeptidyl aminopeptidase-IV inhibitor.
Amsilarotene
go.drugbank.com/drugs/DB21085InvestigationalThe usage of the INN stem '-arotene' in the name indicates that Amsilarotene is a arotinoid derivative.
Guretolimod
go.drugbank.com/drugs/DB21487InvestigationalThe usage of the INN stem '-tolimod' in the name indicates that Guretolimod is a toll-like receptor (TLR) agonist.
Ocedurenone
go.drugbank.com/drugs/DB21519InvestigationalThe usage of the INN stem '-renone' in the name indicates that Ocedurenone is a mineralocorticoid receptor (MR, MCR, aldosterone receptor) antagonist.
Selnoflast
go.drugbank.com/drugs/DB21522InvestigationalThe usage of the INN stem '-noflast' in the name indicates that Selnoflast is a inflammasome protein NLRP3 inhibitor.
Zastaprazan
go.drugbank.com/drugs/DB21524InvestigationalThe usage of the INN stem '-prazan' in the name indicates that Zastaprazan is a proton pump inhibitor, not dependent on acid activation.
Brimarafenib
go.drugbank.com/drugs/DB21706InvestigationalThe usage of the INN stem '-rafenib' in the name indicates that Brimarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.